GEA Reports Solid Performance in a Challenging Environment

18.02.2016

Düsseldorf-based engineering group GEA closed financial year 2015 on a successful note despite the renewed slowdown in economic activity. The preliminary key indicators underscore the Group s sound performance in the year under review.

It should be noted that GEA posted a record operating profit margin, not least thanks to various measures to enhance efficiency that have been initiated or are already in place.

At EUR 4,590 million, order intake was above the level of the previous year, while revenue also increased slightly to EUR 4,599 million. The Group posted operating EBITDA (including effects from currency translation and acquisitions) of EUR 621 million, surpassing the previous year s level, while the corresponding margin rose to 13.5 percent. At 10.3 percent of revenue, the cash-flow driver before non-recurring items in 2015 also eclipsed the prior-year figure.

"Thanks to the outstanding commitment of all our employees, we not only managed to extensively restructure the group as a whole in the course of 2015, but also acquitted ourselves well in an increasingly demanding market environment. In addition, we also closed four bolt-on acquisitions with aggregate annual revenue of more than EUR 120 million," explained Jürg Oleas, CEO of GEA. "Striving to make GEA fit for the future, we launched a great many measures with our program Fit for 2020 whose implementation runs according to plan. The transfer of administrative processes to shared service centers in Eastern Europe and East Asia has begun. Furthermore, we ve reached agreements with the employee representative bodies in all important countries, including Germany and France. This allows us to complete the targeted adjustment of staff capacities in these countries. As a consequence, over half of the staff reductions targeted until 2017 was accomplished by the end of 2015."

In the absence of any further weakening of global economic growth, provided that there are no significant exchange-rate fluctuations, and before new 2016 acquisitions as well as one-offs, GEA is aiming in 2016 for moderate revenue growth, an operating EBITDA of between EUR 645 and EUR 715 million and an operating cash-flow driver margin between 10.0 and 11.0 percent. This forecast includes any realized savings from group restructuring.

All figures for financial year 2015 are preliminary and, as such, have yet to be audited. The consolidated financial statements for GEA and the annual financial statements for GEA Group Aktiengesellschaft are being prepared by the Executive Board and have to be approved by the Supervisory Board at the beginning of March. The annual report with the audited consolidated financial statement will be published on the GEA website on March 10, 2016.

More articles on this topic

ACHEMA 2024 Showcases Solutions for a More Sustainable and Resilient Process Industry

28.03.2024 -

In June, Frankfurt will once again be the centre of the chemical, pharmaceutical and biotechnology industries: The 34th ACHEMA will be opened by the German Federal Minister for Economic Affairs Robert Habeck on June 10. The ACHEMA kick-off will focus on the question of how the process industry can successfully position itself in a changing world. On all five days of the trade show, a diverse programme for young people will also contribute to securing the future of the industry.

Read more

Klaus Endress Celebrates His 75th Birthday

13.12.2023 -

Dr Klaus Endress, CEO of the Endress+Hauser Group for many years and president of the Supervisory Board since 2014, is celebrating his 75th birthday. As previously announced, he will end his active involvement in the family-owned business at the end of the year. However, he will remain closely associated with the Group as a shareholder and chairman of the Endress Family Council.

Read more

Peroxidic-Crosslinked Fluoroelastomer from Freudenberg Meets the Latest Regulatory Requirements of the Process Industry

26.04.2023 -

Freudenberg Sealing Technologies’ peroxidic-crosslinked fluoroelastomer material 75 FKM 239961 now also has received pharma-specific approval according to USP Chapter 87. The result of the in vitro conformity test confirms that the material has no toxic effects on cell cultures. With this advancement, bisphenol crosslinked FKM materials can be replaced in the food industry.

Read more